Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Regulation of cell signalling by uPAR.

Smith HW, Marshall CJ.

Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36. doi: 10.1038/nrm2821. Review.

PMID:
20027185
2.

Role of urokinase receptor in tumor progression and development.

Noh H, Hong S, Huang S.

Theranostics. 2013 Jun 25;3(7):487-95. doi: 10.7150/thno.4218. Print 2013. Review.

3.

RhoB regulates uPAR signalling.

Alfano D, Ragno P, Stoppelli MP, Ridley AJ.

J Cell Sci. 2012 May 15;125(Pt 10):2369-80. doi: 10.1242/jcs.091579. Epub 2012 Feb 24.

4.

The urokinase receptor as an entertainer of signal transduction.

D'Alessio S, Blasi F.

Front Biosci (Landmark Ed). 2009 Jan 1;14:4575-87. Review.

PMID:
19273372
5.

Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.

Czekay RP, Loskutoff DJ.

J Cell Physiol. 2009 Sep;220(3):655-63. doi: 10.1002/jcp.21806.

6.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
7.

Regulation and role of urokinase plasminogen activator in vascular remodelling.

Tkachuk V, Stepanova V, Little PJ, Bobik A.

Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. Review.

PMID:
8911711
8.
9.

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N.

FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. Review.

10.

The interaction between uPAR and vitronectin triggers ligand-independent adhesion signalling by integrins.

Ferraris GM, Schulte C, Buttiglione V, De Lorenzi V, Piontini A, Galluzzi M, Podestà A, Madsen CD, Sidenius N.

EMBO J. 2014 Nov 3;33(21):2458-72. doi: 10.15252/embj.201387611. Epub 2014 Aug 28.

11.

Discovery of new small molecules targeting the vitronectin-binding site of the urokinase receptor that block cancer cell invasion.

Rea VE, Lavecchia A, Di Giovanni C, Rossi FW, Gorrasi A, Pesapane A, de Paulis A, Ragno P, Montuori N.

Mol Cancer Ther. 2013 Aug;12(8):1402-16. doi: 10.1158/1535-7163.MCT-12-1249. Epub 2013 May 22.

13.

uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.

Montuori N, Cosimato V, Rinaldi L, Rea VE, Alfano D, Ragno P.

Thromb Haemost. 2013 Feb;109(2):309-18. doi: 10.1160/TH12-08-0546. Epub 2012 Dec 13.

PMID:
23238745
14.

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F.

Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. Review.

PMID:
12784997
15.

Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.

Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y.

J Cell Sci. 2008 Nov 15;121(Pt 22):3747-56. doi: 10.1242/jcs.029769. Epub 2008 Oct 21.

16.

Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.

Alfano D, Gorrasi A, Li Santi A, Ricci P, Montuori N, Selleri C, Ragno P.

J Cell Mol Med. 2015 Sep;19(9):2262-72. doi: 10.1111/jcmm.12617. Epub 2015 Jun 16.

17.

TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.

Sugioka K, Kodama A, Okada K, Iwata M, Yoshida K, Kusaka S, Matsumoto C, Kaji H, Shimomura Y.

Exp Eye Res. 2013 Oct;115:13-21. doi: 10.1016/j.exer.2013.06.020. Epub 2013 Jun 28.

PMID:
23810810
18.
19.
20.

The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.

Madsen CD, Sidenius N.

Eur J Cell Biol. 2008 Sep;87(8-9):617-29. doi: 10.1016/j.ejcb.2008.02.003. Epub 2008 Mar 18. Review.

PMID:
18353489

Supplemental Content

Support Center